Sort
64,565 grants matching “drug discovery”
Discovery and Preclinical Development of Drugs for Anthrax, Plague and Tularemia
$1,125,082Christie G. Brouillette · University Of Alabama At Birmingham · U01 · FY2006 · AI
Microphysiologial systems and low cost microfluidic platform with analytics
$1,125,000Michael L Shuler · Cornell University · UH2 · FY2012 · TR
Novel Small-Molecule Therapies for CF
$1,124,794Alan S Verkman · University Of California, San Francisco · P30 · FY2012 · DK
Characterization of the Pharmacokinetic/Pharmacodynamic (PK/PD) Profile of a Candidate HIV Prevention Drug in Rhesus Macaques
$1,124,730Pal Ranajit · Advanced Bioscience Laboratories, Inc. · N01 · FY2019 · AI
Core - Drug, Discovery, Design and Synthesis
$1,124,456Gunda I. Georg · University Of Kansas Medical Center · U54 · FY2010 · HD
Interdisciplinary Center for Male Contraceptive Research and Drug Development
$1,124,456Joseph S Tash · University Of Kansas Medical Center · U54 · FY2010 · HD
Development of a Novel Lead Series Against Category A & B Bacterial Pathogens
$1,124,408Terry L Bowlin · Microbiotix, Inc · U01 · FY2010 · AI
DISCOVERY OF NOVEL DRUGS FOR ALZHEIMERS DISEASE
$1,124,242University Of Florida · P01 · FY2000 · AG
Whole Genome Sequencing to Identify Causal Genetic Variants Influencing CVD Risk
$1,124,029John Blangero · University Of Texas Rio Grande Valley · R01 · FY2015 · HL
Engineered tissue-based, high-throughput compound profiling
$1,124,006Victoriya Aleksandrovna Rufanova · Invivo Sciences, Llc. · R44 · FY2011 · GM
Novel Small-Molecule Inhibitors of Bcl-2/Bcl-xL Protein*
$1,123,992Shaomeng Wang · University Of Michigan At Ann Arbor · U19 · FY2007 · CA
Moffitt Cancer Center Support Grant
$1,123,929William S. Dalton · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2009 · CA
Systemic Inflammation in Microphysiological Models of Muscle and Vascular Disease
$1,123,674George A Truskey · Duke University · UH3 · FY2019 · TR
Tissue Chip Modeling of Synovial Joint Pathologies: Effects of Inflammation and Adipose-Mediated Diabetic Complications
$1,123,356Hang Lin · University Of Pittsburgh At Pittsburgh · UH3 · FY2019 · TR
Defining the resistome in P. falciparum: evolution and mechanism
$1,123,100Elizabeth A Winzeler · University Of California, San Diego · R01 · FY2025 · AI
Center for Biomolecular NMR Data Processing and Analysis
$1,122,916Jeffrey C Hoch · University Of Connecticut Sch Of Med/Dnt · P41 · FY2018 · GM
Systemic Inflammation in Microphysiological Models of Muscle and Vascular Disease
$1,122,799George A Truskey · Duke University · UH3 · FY2020 · TR
Emory-GSK-NIMH Collaborative Mood Disorders Initiative
$1,122,582Clinton D Kilts · Emory University · U19 · FY2007 · MH
Novel approaches to monitoring and utilizing adherence to HIV therapy in Africa
$1,122,416David Roy Bangsberg · Massachusetts General Hospital · R01 · FY2014 · MH
Novel Therapies for Alcoholic Hepatitis
$1,122,111Arthur J McCullough · Cleveland Clinic Lerner Com-Cwru · U01 · FY2012 · AA
Antimicrobial Oligomers for BioDefense and Emerging Food Borne Infectious Disease
$1,122,024Gregory N. Tew · University Of Massachusetts Amherst · U01 · FY2013 · AI
Neurometabolomics and Neuroproteomics Center on Cell-Cell Signaling
$1,121,287Jonathan V. Sweedler · University Of Illinois At Urbana-Champaign · P30 · FY2025 · DA
UMGCC Paul Calabresi Clinical Oncology Training Program
$1,121,174Edward A Sausville · University Of Maryland Baltimore · K12 · FY2010 · CA
The Role of B cells in the Origin and Progression of Multiple Sclerosis
$1,121,140Stephen L Hauser · University Of California, San Francisco · R35 · FY2020 · NS
Pacific Northwest Center for Translational Environmental Health Research
$1,121,000Robert L Tanguay · Oregon State University · P30 · FY2020 · ES